Please visit our previous year's here:
Welcome to the 3rd annual conference dedicated to soft mist inhalers (SMI). Learn to make, develop, use, file, launch SMIs, and their place in an inhaled therapy portfolio.
SMIs are capturing 50% of the portable inhaler market. They are THE inhaler device choice for low carbon footprint and for deep lung deposition for local and systemic action. SMIs are versatile, user-friendly, easy to formulate and easily implemented in an inhaler portfolio. SMIs love biologics therapies.